| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |